🇺🇸 FDA
Patent

US 8487097

Reference standard for characterization of rosuvastatin

granted A61PA61P3/06

Quick answer

US patent 8487097 (Reference standard for characterization of rosuvastatin) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P3/06